Article
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.
Acta oncologica (Stockholm, Sweden) - 1 Oct 2014
Beuselinck Benoit, Lambrechts Diether, Van Brussel Thomas, Wolter Pascal, Cardinaels Nina, Joniau Steven, Lerut Evelyne, Karadimou Alexandra, Couchy Gabrielle, Sebe Philippe, Ravaud Alain, Zerbib Marc, Caty Armelle, Paridaens Robert, Schöffski Patrick, Verkarre Virginie, Berger Julien, Patard Jean-Jacques, Zucman-Rossi Jessica, Oudard Stéphane
Abstract excerpt
UNLABELLED: There is growing evidence that sunitinib plasma levels have an impact on treatment outcome in patients with metastatic renal cell carcinoma (mRCC). We studied the impact of single nucleotide polymorphisms (SNPs) in genes involved in sunitinib pharmacokinetics, and additionally, sunitinib pharmacodynamics on dose reductions of the tyrosine kinase inhibitor. METHODS: We retrospectively analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
